DORA WELLS ARTICLES
-
![5_PharmaSource_Conference_CDMO Live copy]( "AI Pilots And Strategic Partnerships")
AI Pilots And Strategic Partnerships9/17/2026Geopolitical uncertainty is reshaping outsourced manufacturing. Discover how industry leaders are leveraging AI, enhancing partnerships, and strengthening supply networks.
-
![PharmaSource_Conference_CDMO Live copy]( "US Pharma Reshoring: The Full Policy Timeline")
US Pharma Reshoring: The Full Policy Timeline9/17/2026As policy shifts and manufacturing investments reshape pharma supply chains, capacity constraints and global dependencies persist. Explore the implications for long-term resilience.
-
![2_PharmaSource_Conference_CDMO Live copy]( "CDMO Quality Oversight: How FDA And Pharma Leaders Are Rethinking Data, AI, And Culture")
CDMO Quality Oversight: How FDA And Pharma Leaders Are Rethinking Data, AI, And Culture9/2/2026Discover strategies for risk-based governance, AI-enabled quality management, stronger collaboration, and fostering a culture that supports long-term operational excellence.
-
![ADC CDMO Selection for Small Biotech]( "ADC CDMO Selection For Small Biotech")
ADC CDMO Selection For Small Biotech8/31/2026Manufacturing is a critical factor in ADC success. Discover how to align CDMO capabilities with molecule complexity, mitigate risks, and navigate capacity limits.
-
![CDMO Selection For Small Biotech Amit Jain On Avoiding Costly Transfers]( "CDMO Selection For Small Biotech: Amit Jain On Avoiding Costly Transfers")
CDMO Selection For Small Biotech: Amit Jain On Avoiding Costly Transfers8/20/2026Make smarter outsourcing decisions early. Reduce the risk of costly tech transfers, evaluate capacity needs, speed development timelines, and strengthen manufacturing partnerships.
-
![PharmaSource_How CDMO Pricing Works]( "The CDMO Pricing Playbook")
The CDMO Pricing Playbook7/27/2026Why do two CDMOs with identical direct costs quote prices 2.6x apart? Learn the three-element pricing framework, capacity utilization math, and market-based strategies that explain every RFQ surprise.
-
![PharmaSource_Reshoring Pressure Meets Manufacturing Reality copy]( "Reshoring Pressure Meets Manufacturing Reality")
Reshoring Pressure Meets Manufacturing Reality7/27/2026U.S. pharma can't reshore what domestic capacity can't absorb. Senior leaders from Takeda, Biogen, Eli Lilly, and others reveal why tariff pressure is colliding with a sterile fill-finish shortage, workforce gaps, and ADC capacity bottlenecks.
-
![PharmaSource_Partnerships for an Uncertain World copy]( "CDMO Live Europe 2026: Partnerships For An Uncertain World")
CDMO Live Europe 2026: Partnerships For An Uncertain World7/27/2026112 pages of executive insight from CDMO Live Europe 2026: tariffs, geopolitics, supply resilience, AI in manufacturing, and why strategic partnerships remain aspirational for most.
-
![PharmaSource_Resilience, Risk, Relationships copy]( "Resilience, Risk, And Relationships: CDMO Live Europe 2026 Report")
Resilience, Risk, And Relationships: CDMO Live Europe 2026 Report7/27/2026Senior pharma leaders from Pfizer, Bayer, BioNTech and others debunk dual sourcing myths and reveal what separates strategic CDMO partnerships from transactional ones.
Dora Wells
Dora Wells is Editor of PharmaSource and Conference Producer for CDMO Live, where she develops and delivers content that connects life sciences professionals with the insights, trends, and expertise shaping the outsourced pharmaceutical industry.
With a background in biomedical sciences and scientific communications, she specializes in creating engaging, data-driven content across articles, interviews, podcasts, and live events. Her work focuses on helping pharmaceutical and biotechnology leaders navigate the opportunities and challenges of drug development, manufacturing, and outsourcing.Wells also serves as moderator and host for industry discussions and conference sessions, facilitating conversations with experts from across the global life sciences community.
Wells studied Biomedical Sciences at the University of Manchester, specializing in molecular and cellular biology. Prior to joining PharmaSource, she spent four years as an editor working with scientific equipment manufacturers to develop digital content marketing campaigns and thought leadership initiatives for technical audiences. Since joining PharmaSource, she has played a key role in shaping editorial strategy and conference programming, curating content that supports meaningful connections and knowledge sharing across the pharmaceutical outsourcing ecosystem.
Passionate about scientific innovation and healthcare accessibility, Wells is committed to delivering content that informs, engages, and advances the life sciences industry.